ECSP078037A - Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] micronizado, y sus sales - Google Patents

Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] micronizado, y sus sales

Info

Publication number
ECSP078037A
ECSP078037A EC2007008037A ECSP078037A ECSP078037A EC SP078037 A ECSP078037 A EC SP078037A EC 2007008037 A EC2007008037 A EC 2007008037A EC SP078037 A ECSP078037 A EC SP078037A EC SP078037 A ECSP078037 A EC SP078037A
Authority
EC
Ecuador
Prior art keywords
micronized
chlorophenyl
immediate release
salts
pharmaceutical formulations
Prior art date
Application number
EC2007008037A
Other languages
English (en)
Inventor
Heiko Kranz
Adrian Funke
Torsten Wagner
Thomas Backensfeld
Kai Juergens
Kai Thode
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ECSP078037A publication Critical patent/ECSP078037A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere a formulaciones farmacéuticas sólidas de liberación inmediata y con una carga de droga elevada que comprenden (4-clorofenil)[4-(4-piridilmetil)-ftalazin-1-ilo] micronizado, así como sus sales aceptables para uso farmacéutico.
EC2007008037A 2005-06-07 2007-12-19 Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] micronizado, y sus sales ECSP078037A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05090167A EP1731154A1 (en) 2005-06-07 2005-06-07 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)|4-(4-pyridylmethyl)pht halazin-1-yl| and salts thereof

Publications (1)

Publication Number Publication Date
ECSP078037A true ECSP078037A (es) 2008-01-23

Family

ID=34938468

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007008037A ECSP078037A (es) 2005-06-07 2007-12-19 Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] micronizado, y sus sales

Country Status (22)

Country Link
EP (2) EP1731154A1 (es)
JP (1) JP2008542421A (es)
KR (1) KR20080017443A (es)
CN (1) CN101242841A (es)
AR (1) AR054377A1 (es)
AU (1) AU2006256853A1 (es)
BR (1) BRPI0611818A2 (es)
CA (1) CA2610977A1 (es)
CR (1) CR9577A (es)
CU (1) CU20070272A7 (es)
DO (1) DOP2006000128A (es)
EC (1) ECSP078037A (es)
GT (1) GT200600243A (es)
IL (1) IL187906A0 (es)
MX (1) MX2007015495A (es)
NO (1) NO20080066L (es)
PE (1) PE20070012A1 (es)
RU (1) RU2007147953A (es)
TW (1) TW200716114A (es)
UY (1) UY29585A1 (es)
WO (1) WO2006131394A1 (es)
ZA (1) ZA200800113B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958616A1 (en) * 2007-02-13 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof
EP1958615A1 (en) * 2007-02-13 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Solid pharmaceutical formulations of a homogeneous dispersion of active principles having pH-dependent solubility
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate
IL315294A (en) 2015-03-03 2024-10-01 Pharmacyclics Llc Pharmaceutical formulations of proton tyrosine kinase inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (es) 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
AU3980499A (en) 1998-05-11 1999-11-29 Endowment for Research in Human Biology, Inc., The Use of neomycin for treating angiogenesis-related diseases

Also Published As

Publication number Publication date
JP2008542421A (ja) 2008-11-27
RU2007147953A (ru) 2009-07-20
GT200600243A (es) 2007-07-16
EP1888073A1 (en) 2008-02-20
CN101242841A (zh) 2008-08-13
TW200716114A (en) 2007-05-01
DOP2006000128A (es) 2006-12-15
PE20070012A1 (es) 2007-02-07
AR054377A1 (es) 2007-06-20
CU20070272A7 (es) 2010-09-30
WO2006131394A1 (en) 2006-12-14
ZA200800113B (en) 2009-07-29
UY29585A1 (es) 2007-01-31
EP1731154A1 (en) 2006-12-13
NO20080066L (no) 2008-03-06
KR20080017443A (ko) 2008-02-26
CR9577A (es) 2008-03-06
IL187906A0 (en) 2008-03-20
BRPI0611818A2 (pt) 2010-09-28
CA2610977A1 (en) 2006-12-14
MX2007015495A (es) 2008-02-22
AU2006256853A1 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
CR10160A (es) Arildihidroisoquinolinas sustituidas con azaciclilo, procedimiento para su preparacion y su uso como medicamentos
MX2009010289A (es) Composiciones para administracion nasal.
UY31456A1 (es) Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
ECSP10010167A (es) Composiciones oftálmicas novedosas
UY30163A1 (es) Nuevas ariltienopirimidinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos
ES2409069R1 (es) Uso de aglutinantes para fabricar formulaciones estables al almacenamiento
UY30165A1 (es) Nuevas arildihidroisoquinolinonas sustituidas con aminolcoholes, procedimiento para su preparación y su uso como medicamentos
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
UY31788A (es) Formulación farmacéutica sólida con liberación retardada
UY33201A (es) Compuestos de pirazol como antagonistas de crth2.
AR053803A1 (es) Uso de acido pinolenico
CR20120058A (es) Composiciones nuevas de 1 - [2 - (2,4-dimetil-fenilsulfanil)-fenil] piperazina
CO6321158A2 (es) Formulacion oral
UY31839A (es) Compuestos
MX2022004523A (es) Formulaciones de liberacion controlada para sustancias fisiologicamente activas altamente lipofilicas.
UY33873A (es) Compuestos de pirazol como antagonistas de crth2
CR9577A (es) Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)
AR058047A1 (es) Administracion de inhibidores de dipeptidil peptidasa
UY31288A1 (es) Nuevos tetrahidronaftalenos sustituidos, procedimiento para su preparacion y uso de los mismos como medicamentos
ECSP078038A (es) Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus sales
PA8802001A1 (es) Combinación antiretroviral novedosa
CU20070271A7 (es) Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-4-piridilmetil) ftalazin-1-ilo] no micronizado y sus sales
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
CR11306A (es) Nuevos compuestos farmaceuticos